<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2017-05-10" version="188">
<accession>P30530</accession>
<accession>Q8N5L2</accession>
<accession>Q9UD27</accession>
<name>UFO_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase receptor UFO</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>AXL oncogene</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AXL</name>
<name type="synonym">UFO</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="8913" last="8917">
<title>Putative tyrosine kinases expressed in K-562 human leukemia cells.</title>
<authorList>
<person name="Partanen J."/>
<person name="Maekelae T.P."/>
<person name="Alitalo R."/>
<person name="Lehvaeslaiho H."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="2247464"/>
<dbReference type="DOI" id="10.1073/pnas.87.22.8913"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ASP-266</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="5016" last="5031">
<title>AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.</title>
<authorList>
<person name="O'Bryan J.P."/>
<person name="Frye R.A."/>
<person name="Cogswell P.C."/>
<person name="Neubauer A."/>
<person name="Kitch B."/>
<person name="Prokop C."/>
<person name="Espinosa R."/>
<person name="le Beau M.M."/>
<person name="Earp H."/>
<person name="Liu E.T."/>
</authorList>
<dbReference type="PubMed" id="1656220"/>
<dbReference type="DOI" id="10.1128/MCB.11.10.5016"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)</scope>
<scope>VARIANT ASP-266</scope>
<scope>ROLE IN MYELOID LEUKEMIA</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="2113" last="2120">
<title>A novel putative tyrosine kinase receptor with oncogenic potential.</title>
<authorList>
<person name="Janssen J.W.G."/>
<person name="Schulz A.S."/>
<person name="Steenvoorden A.C.M."/>
<person name="Schmidberger M."/>
<person name="Strehl S."/>
<person name="Ambros P."/>
<person name="Bartram C.R."/>
</authorList>
<dbReference type="PubMed" id="1834974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>VARIANT ASP-266</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<scope>VARIANT ASP-266</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="3403" last="3410">
<title>A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.</title>
<authorList>
<person name="Lee S.-T."/>
<person name="Strunk K.M."/>
<person name="Spritz R.A."/>
</authorList>
<dbReference type="PubMed" id="8247543"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 674-730</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Int. J. Cancer" volume="60" first="791" last="797">
<title>Receptor tyrosine kinases expressed in metastatic colon cancer.</title>
<authorList>
<person name="Craven R.J."/>
<person name="Xu L.H."/>
<person name="Weiner T.M."/>
<person name="Fridell Y.-W."/>
<person name="Dent G.A."/>
<person name="Srivastava S."/>
<person name="Varnum B."/>
<person name="Liu E.T."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="7896447"/>
<dbReference type="DOI" id="10.1002/ijc.2910600611"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 677-730</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Colon tumor</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Nature" volume="373" first="623" last="626">
<title>Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6.</title>
<authorList>
<person name="Varnum B.C."/>
<person name="Young C."/>
<person name="Elliott G."/>
<person name="Garcia A."/>
<person name="Bartley T.D."/>
<person name="Fridell Y.W."/>
<person name="Hunt R.W."/>
<person name="Trail G."/>
<person name="Clogston C."/>
<person name="Toso R.J."/>
<person name="Yanagihara D."/>
<person name="Bennett L."/>
<person name="Silber M."/>
<person name="Merewether L.A."/>
<person name="Tseng A."/>
<person name="Escobar E."/>
<person name="Liu E.T."/>
<person name="Yamane H.K."/>
</authorList>
<dbReference type="PubMed" id="7854420"/>
<dbReference type="DOI" id="10.1038/373623a0"/>
</citation>
<scope>INTERACTION WITH LIGAND GAS6</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="9785" last="9789">
<title>Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl.</title>
<authorList>
<person name="Mark M.R."/>
<person name="Chen J."/>
<person name="Hammonds R.G."/>
<person name="Sadick M."/>
<person name="Godowski P.J."/>
</authorList>
<dbReference type="PubMed" id="8621659"/>
<dbReference type="DOI" id="10.1074/jbc.271.16.9785"/>
</citation>
<scope>INTERACTION WITH GAS6</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="2619" last="2631">
<title>Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site.</title>
<authorList>
<person name="Braunger J."/>
<person name="Schleithoff L."/>
<person name="Schulz A.S."/>
<person name="Kessler H."/>
<person name="Lammers R."/>
<person name="Ullrich A."/>
<person name="Bartram C.R."/>
<person name="Janssen J.W."/>
</authorList>
<dbReference type="PubMed" id="9178760"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201123"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-779; TYR-821 AND TYR-866</scope>
<scope>INTERACTION WITH GRB2; LCK; PIK3R1; PIK3R2 AND PLCG1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Cancer Detect. Prev." volume="23" first="325" last="332">
<title>A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145.</title>
<authorList>
<person name="Jacob A.N."/>
<person name="Kalapurakal J."/>
<person name="Davidson W.R."/>
<person name="Kandpal G."/>
<person name="Dunson N."/>
<person name="Prashar Y."/>
<person name="Kandpal R.P."/>
</authorList>
<dbReference type="PubMed" id="10403904"/>
<dbReference type="DOI" id="10.1046/j.1525-1500.1999.99034.x"/>
</citation>
<scope>ROLE IN PROSTATIC CARCINOMA</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Ann. Oncol." volume="12" first="819" last="824">
<title>Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast.</title>
<authorList>
<person name="Berclaz G."/>
<person name="Altermatt H.J."/>
<person name="Rohrbach V."/>
<person name="Kieffer I."/>
<person name="Dreher E."/>
<person name="Andres A.C."/>
</authorList>
<dbReference type="PubMed" id="11484958"/>
<dbReference type="DOI" id="10.1023/A:1011126330233"/>
</citation>
<scope>ROLE IN BREAST CANCER</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="299" first="793" last="800">
<title>Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.</title>
<authorList>
<person name="Hafizi S."/>
<person name="Alindri F."/>
<person name="Karlsson R."/>
<person name="Dahlbaeck B."/>
</authorList>
<dbReference type="PubMed" id="12470648"/>
<dbReference type="DOI" id="10.1016/S0006-291X(02)02718-3"/>
</citation>
<scope>INTERACTION WITH NCK2; PIK3R3; SOCS1 AND TNS2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Circ. Res." volume="91" first="E4" last="12">
<title>Acidification prevents endothelial cell apoptosis by Axl activation.</title>
<authorList>
<person name="D'Arcangelo D."/>
<person name="Gaetano C."/>
<person name="Capogrossi M.C."/>
</authorList>
<dbReference type="PubMed" id="12364394"/>
<dbReference type="DOI" id="10.1161/01.RES.0000036753.50601.E9"/>
</citation>
<scope>FUNCTION OF THE GAS6/AXL SIGNALING PATHWAY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Thyroid" volume="12" first="971" last="975">
<title>Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around Chernobyl.</title>
<authorList>
<person name="Ito M."/>
<person name="Nakashima M."/>
<person name="Nakayama T."/>
<person name="Ohtsuru A."/>
<person name="Nagayama Y."/>
<person name="Takamura N."/>
<person name="Demedchik E.P."/>
<person name="Sekine I."/>
<person name="Yamashita S."/>
</authorList>
<dbReference type="PubMed" id="12490074"/>
<dbReference type="DOI" id="10.1089/105072502320908303"/>
</citation>
<scope>ROLE IN THYROID CARCINOMAS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="333" first="180" last="185">
<title>Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation.</title>
<authorList>
<person name="Valverde P."/>
</authorList>
<dbReference type="PubMed" id="15958209"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.05.086"/>
</citation>
<scope>INTERACTION WITH CBL AND GAS6</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Blood" volume="105" first="1970" last="1976">
<title>Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor.</title>
<authorList>
<person name="Gallicchio M."/>
<person name="Mitola S."/>
<person name="Valdembri D."/>
<person name="Fantozzi R."/>
<person name="Varnum B."/>
<person name="Avanzi G.C."/>
<person name="Bussolino F."/>
</authorList>
<dbReference type="PubMed" id="15507525"/>
<dbReference type="DOI" id="10.1182/blood-2004-04-1469"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Thromb. Haemost." volume="3" first="733" last="741">
<title>Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses.</title>
<authorList>
<person name="Gould W.R."/>
<person name="Baxi S.M."/>
<person name="Schroeder R."/>
<person name="Peng Y.W."/>
<person name="Leadley R.J."/>
<person name="Peterson J.T."/>
<person name="Perrin L.A."/>
</authorList>
<dbReference type="PubMed" id="15733062"/>
<dbReference type="DOI" id="10.1111/j.1538-7836.2005.01186.x"/>
</citation>
<scope>FUNCTION IN PLATELET ACTIVATION AND THROMBOTIC RESPONSE REGULATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="J. Virol." volume="80" first="10109" last="10116">
<title>Tyro3 family-mediated cell entry of Ebola and Marburg viruses.</title>
<authorList>
<person name="Shimojima M."/>
<person name="Takada A."/>
<person name="Ebihara H."/>
<person name="Neumann G."/>
<person name="Fujioka K."/>
<person name="Irimura T."/>
<person name="Jones S."/>
<person name="Feldmann H."/>
<person name="Kawaoka Y."/>
</authorList>
<dbReference type="PubMed" id="17005688"/>
<dbReference type="DOI" id="10.1128/JVI.01157-06"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Neurochem." volume="106" first="134" last="146">
<title>In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.</title>
<authorList>
<person name="Weinger J.G."/>
<person name="Gohari P."/>
<person name="Yan Y."/>
<person name="Backer J.M."/>
<person name="Varnum B."/>
<person name="Shafit-Zagardo B."/>
</authorList>
<dbReference type="PubMed" id="18346204"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2008.05343.x"/>
</citation>
<scope>INTERACTION WITH GRB2; PIK3R1 AND PIK3R2</scope>
<scope>PHOSPHORYLATION AT TYR-779; TYR-821 AND TYR-866</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-884</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Blood" volume="113" first="2470" last="2477">
<title>The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.</title>
<authorList>
<person name="Park I.K."/>
<person name="Giovenzana C."/>
<person name="Hughes T.L."/>
<person name="Yu J."/>
<person name="Trotta R."/>
<person name="Caligiuri M.A."/>
</authorList>
<dbReference type="PubMed" id="18840707"/>
<dbReference type="DOI" id="10.1182/blood-2008-05-157073"/>
</citation>
<scope>FUNCTION OF THE GAS6/AXL SIGNALING PATHWAY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="34954" last="34963">
<title>Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.</title>
<authorList>
<person name="Pao-Chun L."/>
<person name="Chan P.M."/>
<person name="Chan W."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="19815557"/>
<dbReference type="DOI" id="10.1074/jbc.M109.072660"/>
</citation>
<scope>INTERACTION WITH GRB2 AND TNK2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Cell Host Microbe" volume="9" first="286" last="298">
<title>The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry.</title>
<authorList>
<person name="Morizono K."/>
<person name="Xie Y."/>
<person name="Olafsen T."/>
<person name="Lee B."/>
<person name="Dasgupta A."/>
<person name="Wu A.M."/>
<person name="Chen I.S."/>
</authorList>
<dbReference type="PubMed" id="21501828"/>
<dbReference type="DOI" id="10.1016/j.chom.2011.03.012"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="J. Virol." volume="86" first="2067" last="2078">
<title>Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.</title>
<authorList>
<person name="Shimojima M."/>
<person name="Stroher U."/>
<person name="Ebihara H."/>
<person name="Feldmann H."/>
<person name="Kawaoka Y."/>
</authorList>
<dbReference type="PubMed" id="22156524"/>
<dbReference type="DOI" id="10.1128/JVI.06451-11"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="J. Vet. Med. Sci." volume="74" first="1363" last="1366">
<title>Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein.</title>
<authorList>
<person name="Shimojima M."/>
<person name="Kawaoka Y."/>
</authorList>
<dbReference type="PubMed" id="22673088"/>
<dbReference type="DOI" id="10.1292/jvms.12-0176"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Virology" volume="468" first="565" last="580">
<title>Phosphatidylserine receptors: enhancers of enveloped virus entry and infection.</title>
<authorList>
<person name="Moller-Tank S."/>
<person name="Maury W."/>
</authorList>
<dbReference type="PubMed" id="25277499"/>
<dbReference type="DOI" id="10.1016/j.virol.2014.09.009"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>REVIEW</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="80" last="87">
<title>Structural basis for Gas6-Axl signalling.</title>
<authorList>
<person name="Sasaki T."/>
<person name="Knyazev P.G."/>
<person name="Clout N.J."/>
<person name="Cheburkin Y."/>
<person name="Goehring W."/>
<person name="Ullrich A."/>
<person name="Timpl R."/>
<person name="Hohenester E."/>
</authorList>
<dbReference type="PubMed" id="16362042"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600912"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 33-227 IN COMPLEX WITH GAS6</scope>
<scope>MUTAGENESIS OF GLU-63; GLU-66 AND THR-84</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] MET-112; TRP-295; CYS-499 AND GLY-515</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 13 15 16 19 24">Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factor GAS6 and which is thus regulating many physiological processes including cell survival, cell proliferation, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of AXL. Following activation by ligand, ALX binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3; but also GRB2, PLCG1, LCK and PTPN11. Other downstream substrate candidates for AXL are CBL, NCK2, SOCS1 and TNS2. Recruitment of GRB2 and phosphatidylinositol 3 kinase regulatory subunits by AXL leads to the downstream activation of the AKT kinase. GAS6/AXL signaling plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal cytokine signaling during human natural killer cell development, hepatic regeneration, gonadotropin-releasing hormone neuron survival and migration, platelet activation, or regulation of thrombotic responses. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response.</text>
</comment>
<comment type="function">
<text evidence="20 26 27 29 30">(Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope (PubMed:22156524, PubMed:22673088, PubMed:25277499, PubMed:21501828). Acts as a receptor for ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope (PubMed:17005688).</text>
</comment>
<comment type="catalytic activity">
<text evidence="8">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="15 33">Activated by GAS6-binding and subsequent autophosphorylation.</text>
</comment>
<comment type="subunit">
<text evidence="12 17 18 22 25 31 33 34">Heterodimer and heterotetramer with ligand GAS6. Interacts with CBL, GRB2, LCK, NCK2, PIK3R1, PIK3R2, PIK3R3, PLCG1, SOCS1 and TNS2. Part of a complex including AXL, TNK2 and GRB2, in which GRB2 promotes AXL recruitment by TNK2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2850927"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2850927"/>
<interactant intactId="EBI-2802811">
<id>Q14393</id>
<label>GAS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2850927"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="32">Cell membrane</location>
<topology evidence="32">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P30530-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P30530-2</id>
<name>Short</name>
<sequence type="described" ref="VSP_005017"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="32">Highly expressed in metastatic colon tumors. Expressed in primary colon tumors. Weakly expressed in normal colon tissue.</text>
</comment>
<comment type="PTM">
<text evidence="17">Monoubiquitinated upon GAS6-binding. A very small proportion of the receptor could be subjected to polyubiquitination in a very transient fashion.</text>
</comment>
<comment type="PTM">
<text evidence="22 34">Phosphorylated at tyrosine residues by autocatalysis, which activates kinase activity.</text>
</comment>
<comment type="disease">
<text>AXL and its ligand GAS6 are highly expressed in thyroid carcinoma tissues, and might thus be involved in thyroid tumorigenesis. Overexpression of AXL and its ligand was also detected in many other cancers such as myeloproliferative disorders, prostatic carcinoma cells, or breast cancer.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the protein kinase superfamily. Tyr protein kinase family. AXL/UFO subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/AXLID733ch19q13.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="M76125">
<property type="protein sequence ID" value="AAA61243.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S65125">
<property type="protein sequence ID" value="AAB20305.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X57019">
<property type="protein sequence ID" value="CAA40338.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011510">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032229">
<property type="protein sequence ID" value="AAH32229.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12574.1">
<molecule id="P30530-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12575.1">
<molecule id="P30530-1"/>
</dbReference>
<dbReference type="PIR" id="A41527">
<property type="entry name" value="A41527"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001690.2">
<property type="nucleotide sequence ID" value="NM_001699.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068713.2">
<property type="nucleotide sequence ID" value="NM_021913.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.590970"/>
<dbReference type="PDB" id="2C5D">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="C/D=33-227"/>
</dbReference>
<dbReference type="PDB" id="4RA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.07"/>
<property type="chains" value="C/D=33-227"/>
</dbReference>
<dbReference type="PDBsum" id="2C5D"/>
<dbReference type="PDBsum" id="4RA0"/>
<dbReference type="ProteinModelPortal" id="P30530"/>
<dbReference type="SMR" id="P30530"/>
<dbReference type="BioGrid" id="107036">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="IntAct" id="P30530">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="MINT-2735752"/>
<dbReference type="STRING" id="9606.ENSP00000301178"/>
<dbReference type="BindingDB" id="P30530"/>
<dbReference type="ChEMBL" id="CHEMBL4895"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1835"/>
<dbReference type="iPTMnet" id="P30530"/>
<dbReference type="PhosphoSitePlus" id="P30530"/>
<dbReference type="BioMuta" id="AXL"/>
<dbReference type="DMDM" id="239938818"/>
<dbReference type="EPD" id="P30530"/>
<dbReference type="MaxQB" id="P30530"/>
<dbReference type="PaxDb" id="P30530"/>
<dbReference type="PeptideAtlas" id="P30530"/>
<dbReference type="PRIDE" id="P30530"/>
<dbReference type="DNASU" id="558"/>
<dbReference type="Ensembl" id="ENST00000301178">
<property type="protein sequence ID" value="ENSP00000301178"/>
<property type="gene ID" value="ENSG00000167601"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359092">
<property type="protein sequence ID" value="ENSP00000351995"/>
<property type="gene ID" value="ENSG00000167601"/>
</dbReference>
<dbReference type="GeneID" id="558"/>
<dbReference type="KEGG" id="hsa:558"/>
<dbReference type="UCSC" id="uc010ehj.5">
<molecule id="P30530-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="558"/>
<dbReference type="DisGeNET" id="558"/>
<dbReference type="GeneCards" id="AXL"/>
<dbReference type="HGNC" id="HGNC:905">
<property type="gene designation" value="AXL"/>
</dbReference>
<dbReference type="HPA" id="CAB032501"/>
<dbReference type="HPA" id="HPA037422"/>
<dbReference type="HPA" id="HPA037423"/>
<dbReference type="MIM" id="109135">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P30530"/>
<dbReference type="PharmGKB" id="PA25197"/>
<dbReference type="eggNOG" id="ENOG410IG6I">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000231685"/>
<dbReference type="HOVERGEN" id="HBG006346"/>
<dbReference type="InParanoid" id="P30530"/>
<dbReference type="KO" id="K05115"/>
<dbReference type="OrthoDB" id="EOG091G016X"/>
<dbReference type="PhylomeDB" id="P30530"/>
<dbReference type="TreeFam" id="TF317402"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420097">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="SignaLink" id="P30530"/>
<dbReference type="SIGNOR" id="P30530"/>
<dbReference type="ChiTaRS" id="AXL">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P30530"/>
<dbReference type="GeneWiki" id="AXL_receptor_tyrosine_kinase"/>
<dbReference type="GenomeRNAi" id="558"/>
<dbReference type="PRO" id="PR:P30530"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000167601"/>
<dbReference type="CleanEx" id="HS_AXL"/>
<dbReference type="ExpressionAtlas" id="P30530">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P30530">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044228">
<property type="term" value="C:host cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0032036">
<property type="term" value="F:myosin heavy chain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043548">
<property type="term" value="F:phosphatidylinositol 3-kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001786">
<property type="term" value="F:phosphatidylserine binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043277">
<property type="term" value="P:apoptotic cell clearance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001974">
<property type="term" value="P:blood vessel remodeling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031668">
<property type="term" value="P:cellular response to extracellular stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035457">
<property type="term" value="P:cellular response to interferon-alpha"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097028">
<property type="term" value="P:dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034101">
<property type="term" value="P:erythrocyte homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021885">
<property type="term" value="P:forebrain cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001779">
<property type="term" value="P:natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000669">
<property type="term" value="P:negative regulation of dendritic cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051250">
<property type="term" value="P:negative regulation of lymphocyte activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097350">
<property type="term" value="P:neutrophil clearance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042698">
<property type="term" value="P:ovulation cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001961">
<property type="term" value="P:positive regulation of cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032825">
<property type="term" value="P:positive regulation of natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048549">
<property type="term" value="P:positive regulation of pinocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032940">
<property type="term" value="P:secretion by cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034446">
<property type="term" value="P:substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060068">
<property type="term" value="P:vagina development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046718">
<property type="term" value="P:viral entry into host cell"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0553">Oncogene</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Tyrosine-protein kinase receptor UFO" id="PRO_0000024481">
<location>
<begin position="26"/>
<end position="894"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="26"/>
<end position="451"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="452"/>
<end position="472"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="473"/>
<end position="894"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="27"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="139"/>
<end position="222"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="7">
<location>
<begin position="227"/>
<end position="331"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="7">
<location>
<begin position="336"/>
<end position="428"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="536"/>
<end position="807"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="542"/>
<end position="550"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with GAS6">
<location>
<begin position="26"/>
<end position="92"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 8">
<location>
<position position="672"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="6">
<location>
<position position="567"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="3">
<location>
<position position="703"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="22 34">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="22 34">
<location>
<position position="821"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="22 34">
<location>
<position position="866"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="884"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="43"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="157"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="198"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="339"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="345"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="401"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="56"/>
<end position="117"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="160"/>
<end position="205"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_005017" evidence="35">
<location>
<begin position="429"/>
<end position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35202236." id="VAR_045596" evidence="21">
<original>T</original>
<variation>M</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7249222." id="VAR_057990" evidence="14 19 23 28">
<original>N</original>
<variation>D</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung neuroendocrine carcinoma sample; somatic mutation." id="VAR_045597" evidence="21">
<original>R</original>
<variation>W</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_041877" evidence="21">
<original>R</original>
<variation>C</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_041878" evidence="21">
<original>S</original>
<variation>G</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced affinity for GAS6." evidence="18">
<original>E</original>
<variation>R</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for GAS6." evidence="18">
<original>E</original>
<variation>R</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for GAS6." evidence="18">
<original>T</original>
<variation>R</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB20305/CAA40338." ref="3" evidence="36">
<original>T</original>
<variation>P</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA61243." ref="2" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB20305/CAA40338." ref="3" evidence="36">
<original>Q</original>
<variation>E</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB20305/CAA40338." ref="3" evidence="36">
<original>D</original>
<variation>G</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; no nucleotide entry." ref="7" evidence="36">
<original>K</original>
<variation>I</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH32229." ref="5" evidence="36">
<original>Q</original>
<variation>R</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="52"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="113"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="140"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="156"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="170"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="178"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="190"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="201"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="219"/>
<end position="223"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RA0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10403904"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11484958"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12364394"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12470648"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12490074"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15507525"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15733062"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15958209"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16362042"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1656220"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17005688"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18346204"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1834974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18840707"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19815557"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21501828"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22156524"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2247464"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22673088"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25277499"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7854420"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7896447"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8621659"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9178760"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1656220"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305"/>
<sequence length="894" mass="98336" checksum="2C2D3574EADA4116" modified="2009-06-16" version="3" precursor="true">
MAWRCPRMGRVPLAWCLALCGWACMAPRGTQAEESPFVGNPGNITGARGLTGTLRCQLQV
QGEPPEVHWLRDGQILELADSTQTQVPLGEDEQDDWIVVSQLRITSLQLSDTGQYQCLVF
LGHQTFVSQPGYVGLEGLPYFLEEPEDRTVAANTPFNLSCQAQGPPEPVDLLWLQDAVPL
ATAPGHGPQRSLHVPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQQPRNLHLVSRQPTE
LEVAWTPGLSGIYPLTHCTLQAVLSNDGMGIQAGEPDPPEEPLTSQASVPPHQLRLGSLH
PHTPYHIRVACTSSQGPSSWTHWLPVETPEGVPLGPPENISATRNGSQAFVHWQEPRAPL
QGTLLGYRLAYQGQDTPEVLMDIGLRQEVTLELQGDGSVSNLTVCVAAYTAAGDGPWSLP
VPLEAWRPGQAQPVHQLVKEPSTPAFSWPWWYVLLGAVVAAACVLILALFLVHRRKKETR
YGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGK
TLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRL
IGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGM
EYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES
LADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYA
LMSRCWELNPQDRPSFTELREDLENTLKALPPAQEPDEILYVNMDEGGGYPEPPGAAGGA
DPPTQPDPKDSCSCLTAAEVHPAGRYVLCPSTTPSPAQPADRGSPAAPGQEDGA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>